Expanding Horizons in Neuroprosthetics: A Conversation with Andreas Forsland
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
Release Date: 01/27/2025
Ignacio Sáez - Neurotechnology for Cognition: Recording and Modulating the Human Brain
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, host Dr. Ladan Jiracek sits down with Dr. , , whose lab uses intracranial brain recordings to study the biology of human cognition. Ignacio shares how cutting-edge neurotechnology like iEEG can reveal the neural dynamics behind decision-making, risk, memory, and brain states - and how those insights could unlock more targeted neuromodulation therapies for psychiatric disorders such as depression and anxiety. Top 3 Takeaways: Epilepsy patients undergoing seizure monitoring often have 100-200 electrodes implanted in their brains and may...
info_outline
Dr. Ladan Jiracek - My PhD Defense, LCP Neural Implants, and What’s Next
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this solo episode of the Neural Implant Podcast, host Dr. Ladan Jiracek shares the story behind finally completing his PhD at the University of Florida - from the highs of passing his dissertation defense to the long, frustrating, and deeply technical journey of developing liquid crystal polymer (LCP)-based neural implants. I break down why LCP is so promising for long-term implantable devices, how delamination and bonding challenges became the core focus of his dissertation, and what it took to fabricate ultra-thin polymer electrodes approaching “biological invisibility.” I also...
info_outline
Paul Goode: Implantable Glucose Monitoring—and a Neural Interface Twist
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, Paul Goode (Glucotrack) dives into the next wave of continuous glucose monitoring: an active, fully implantable CGM designed to deliver long-term, pacemaker-style reliability without external wearables. We discuss first-in-human progress, why implantables may change diabetes care at home, and a fascinating neural angle—how similar chemistry and form factors could be adapted to epidural glucose sensing and even paired with neural recording electrodes to capture metabolic and neural data together. If you care about closed-loop systems, chronic implants, or bridging...
info_outline
Fabio Boi on Corticale’s Ultra-Dense, Minimally Invasive Brain Interfaces
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, I speak with , Co-Founder and CSO of , an Italian neurotech company that is redefining the landscape of brain-computer interfaces. Corticale is pioneering a new generation of minimally invasive, CMOS-based neural implants that can record from thousands of neurons simultaneously—introducing their flagship technology, SiNAPS. Fabio walks us through how SiNAPS achieves single-cell resolution recordings via its 1024-electrode array, enabling high-fidelity access to both action potentials and local field potentials deep within cortical tissue. We...
info_outline
Ben Woodington on Coherence Bio's Revolutionary Cancer Reprogramming Approach
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, we sit down with , co-founder of , a groundbreaking medical technology company pioneering a new frontier in cancer treatment. By integrating neurotechnology, neurobiology, and machine learning, Coherence is building a platform that doesn't just fight cancer—it manages it in real time. Ben shares how Coherence is moving beyond the traditional "cut, burn, poison" model of oncology, and instead focusing on precision neuromodulation to monitor and control cancer progression—offering hope for 24/7 adaptive treatment with fewer side effects and...
info_outline
Dr Christian Wende on European IP Strategy, Medtech Patents & the UPC
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we dive into the world of European intellectual property and medtech innovation with , a German and European Patent Attorney specializing in medical technology at . With a background in mechanical engineering, a Ph.D. in liver dialysis research, and a Master of Laws in European IP law, Christian brings a rare and powerful combination of technical, legal, and clinical insight. We explore how startups and investors should think about IP strategy in Europe, the impact of the new Unified Patent Court (UPC), the nuances between U.S. and EU patent landscapes, and how IP due...
info_outline
Inside AIMD: Building the Future of Implantable Devices with Nicolas Barabino & Antoni Ivarra
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special episode recorded after the workshop in Barcelona, I talk with and , two of the key organizers behind the . We dive into the vision behind this growing event, which brings together top researchers, engineers, clinicians, and entrepreneurs to explore the cutting edge of implantable medical devices. Nicolas and Antoni share insights on the evolution of AIMD technologies, the role of multidisciplinary collaboration, and how this annual workshop is shaping the next generation of innovators. We also touch on the challenges that startups face in the space—regulatory hurdles, IP...
info_outline
Chad Andresen on Lunosa’s Injectable Neurostimulator and Lessons from Stimwave
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we sit down with , Chief Business Officer of , to explore a groundbreaking approach to treating obstructive sleep apnea. Lunosa is developing a self-expanding, injectable neurostimulator that aims to replace invasive facial surgeries with a minimally invasive, high-impact solution — tapping into a $10 billion market. Chad also reflects on his time at , a pioneering neuromodulation company that saw both innovation and controversy. He shares insights from testifying against Stimwave’s former CEO, lessons learned from the company’s collapse, and how those experiences shape...
info_outline
Frederik Ceyssens and the ReVision Implant Team: Building a Visual Cortical Prosthesis to Restore Sight
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special on-location episode recorded in Leuven, Belgium, we sit down with the co-founders and technical leaders of — (CEO), (CTO), and (CSO). The team shares their journey developing a high-density, intracortical visual prosthesis aimed at restoring vision for the blind. From developing reliable insertion technology to achieving long-term biocompatibility in nonhuman primate models, ReVision Implant is at the forefront of neurotech innovation. Tune in to hear about their challenges, breakthroughs, and what’s next in the race to cure blindness through brain stimulation. This...
info_outline
Julio Martinez-Clark: Accelerating Clinical Trials Through Latin America with Bioaccess
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we speak with , CEO and co-founder of , a contract research organization helping Medtech and Biopharma startups slash months off their clinical timelines. With a focus on Latin America, Bioaccess enables early feasibility and first-in-human trials to be conducted faster, more affordably, and with high-quality data suitable for FDA and EU submissions. Julio shares how their global site network—built over 20 years—helps startups navigate regulatory hurdles, reduce costs, and de-risk innovation, all while improving patient lives in emerging markets. This episode is sponsored...
info_outline- "We aimed to make it easy for both non-technical and technical users to build simple research applications as well as complex, immersive commercial applications. Initially, it was an internal product we developed for rapid prototyping and exploring neurophysiology. But we realized many others wanted the same capabilities to build their own apps."
- "Go ahead and integrate with Apple Vision Pro or a Meta Quest device, but be aware that you're going to face a lot of problems. The clinical trial process is expensive and time-consuming, and what we've found is that some people who’ve tried this route end up with only 10 to 15 percent usable data. Wasting 80 to 85 percent of your data because of poor technology or failure to meet IRB standards for medical safety and efficacy is a huge waste. If you're pursuing anything in healthcare, you need to build on a reliable platform like Cognixion."
- "You could invest in 10 software-as-a-medical-device (SMD) applications, which are subscription-based or software-based apps that deliver clinically valid outcomes. Building and validating such an application might cost anywhere from $3 to $10 million to bring it to commercialization. In contrast, building a traditional medical device could cost anywhere from $25 to $200 million, usually for just one indication. The key cost savings here is that you don’t need to invest in bespoke hardware—we've already invested over $25 million in developing the validated hardware and platform."